Ebselen
Showing 1 - 14 of 14
Ototoxicity Trial in Charleston (Placebo, SPI-1005 Ebselen 200mg Capsule x1, SPI-1005 Ebselen 200mg Capsule x2)
Enrolling by invitation
- Ototoxicity
- Placebo
- +3 more
-
Charleston, South CarolinaMedical University of South Carolina
Dec 7, 2022
Depressive Disorder, Treatment-Resistant Trial in Oxford (Ebselen, Placebo)
Recruiting
- Depressive Disorder, Treatment-Resistant
- Ebselen
- Placebo
-
Oxford, Oxfordshire, United KingdomNeurosciences Building, Dept. Psychiatry, Warneford Hospital
Dec 15, 2021
Covid19, Coronavirus, Coronavirus Infection Trial in United States (Ebselen, Placebo)
Enrolling by invitation
- Covid19
- +3 more
- Ebselen
- Placebo
-
New Haven, Connecticut
- +6 more
Apr 5, 2022
Covid19, Corona Virus Infection, Coronavirus Trial in United States (Ebselen, Placebo)
Enrolling by invitation
- Covid19
- +3 more
- Ebselen
- Placebo
-
New Haven, Connecticut
- +6 more
Apr 5, 2022
Meniere Disease, Ménière Trial in United States (Ebselen, Placebo)
Recruiting
- Meniere Disease
- Ménière
- Ebselen
- Placebo
-
Little Rock, Arkansas
- +14 more
Jan 3, 2023
Meniere's Disease Trial in United States (200mg SPI-1005 BID, 400mg SPI-1005 BID, Placebo)
Completed
- Meniere's Disease
- 200mg SPI-1005 BID
- +2 more
-
Fresno, California
- +12 more
Mar 15, 2021
Bipolar Disorder, Bipolar Disorder, Manic Trial in Oxford (Ebselen, Placebo oral capsule)
Completed
- Bipolar Disorder
- Bipolar Disorder, Manic
- Ebselen
- Placebo oral capsule
-
Oxford, Oxfordshire, United KingdomNeurosciences Building, Dept. Psychiatry, Warneford Hospital
Sep 5, 2019
Brain Aneurysms: Utility of Cisternal Urokinase Irrigation
Completed
- Subarachnoid Hemorrhage, Aneurysmal
- +2 more
- Urokinase
- +3 more
-
Valencia, SpainHospital General Universitario de Valencia
Mar 7, 2021
Lung Cancer, Head Neck Cancer, Hearing Loss Trial in Seattle (SPI-1005 Low Dose, SPI-1005 Middle Dose, SPI-1005 High Dose)
Unknown status
- Lung Cancer
- +5 more
- SPI-1005 Low Dose
- +3 more
-
Seattle, WashingtonVA Puget Sound Health Care
Sep 21, 2017
Noise Induced Hearing Loss Trial in United States (SPI-1005 200mg, SPI-1005 400mg, Placebo)
Unknown status
- Noise Induced Hearing Loss
- SPI-1005 200mg
- +2 more
-
Miami, Florida
- +4 more
Aug 22, 2018
Temporary Auditory Threshold Shift Trial in Gainsville (SPI-1005 Low dose, SPI-1005 Middle dose, SPI-1005 High dose)
Completed
- Temporary Auditory Threshold Shift
- SPI-1005 Low dose
- +3 more
-
Gainsville, FloridaUniversity of Florida
Aug 26, 2014
Type 1 Diabetes, Type 2 Diabetes Trial in Boston (Ebselen, Placebo)
Completed
- Type 1 Diabetes Mellitus
- Type 2 Diabetes Mellitus
- Ebselen
- Placebo
-
Boston, MassachusettsBrigham and Women's Hosptial
Sep 29, 2008